The Little Canada-based company develops medical technology, products and services that treat cardiac, neurological and chronic pain patients.
Delayed Price / Updated: /
|52 Week High||71.90|
|52 Week Low||54.80|
|Today's Range||65.82 - 63.85|
Don’t bother with the marketing pitch. Suzanne Belinson wants to see the hard data.Belinson is executive director of Blue Cross and Blue Shield’s Clinical Effectiveness Center, which has...
One of the most reviled taxes in recent memory, the medical device excise tax, seems to be near the end of its short life.Enacted as part of the Affordable Care Act, it’s been under fire from...
Tuesday’s Republican victories in Washington inspired strong optimism among medical device companies in Minnesota and nationwide for a repeal of the 2.3 percent sales tax on their...
St. Jude Medical has received approval to sell a device that should let doctors more accurately perform ablation procedures that aim to correct an irregular heartbeat by destroying tiny bits of...
St. Jude Medical Inc. reported an 8 percent jump in its adjusted profit for the third quarter, but the company lowered its revenue guidance for the fourth quarter.The medical device maker said...
|Current year rank||30|
|Current year compensation||$3,698,451|
|Percent change of the CEO||26.0|
The Little Canada-based company is beginning to enroll U.S. patients in a clinical study of its new spinal cord stimulation system, which delivers what it calls burst stimulation.
Minnesota Topics are a comprehensive collection of Star Tribune content on select people, places and companies.